Annual Accounts Payable
$3.91 M
-$1.91 M-32.82%
December 31, 2023
Summary
- As of February 27, 2025, INKT annual accounts payable is $3.91 million, with the most recent change of -$1.91 million (-32.82%) on December 31, 2023.
- During the last 3 years, INKT annual accounts payable has risen by +$770.20 thousand (+24.51%).
- INKT annual accounts payable is now -32.82% below its all-time high of $5.82 million, reached on December 31, 2022.
Performance
INKT Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$2.36 M
-$840.90 K-26.26%
September 30, 2024
Summary
- As of February 27, 2025, INKT quarterly accounts payable is $2.36 million, with the most recent change of -$840.90 thousand (-26.26%) on September 30, 2024.
- Over the past year, INKT quarterly accounts payable has stayed the same.
- INKT quarterly accounts payable is now -60.66% below its all-time high of $6.00 million, reached on March 31, 2023.
Performance
INKT Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
INKT Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.8% | 0.0% |
| 3 y3 years | +24.5% | 0.0% |
| 5 y5 years | +59.3% | 0.0% |
INKT Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -32.8% | +30.6% | -60.7% | at low |
| 5 y | 5-year | -32.8% | +59.3% | -60.7% | +43.3% |
| alltime | all time | -32.8% | +59.3% | -60.7% | +43.3% |
MiNK Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.36 M(-26.3%) |
| Jun 2024 | - | $3.20 M(-8.2%) |
| Mar 2024 | - | $3.49 M(-10.9%) |
| Dec 2023 | $3.91 M(-32.8%) | $3.91 M(-8.6%) |
| Sep 2023 | - | $4.28 M(-12.4%) |
| Jun 2023 | - | $4.89 M(-18.6%) |
| Mar 2023 | - | $6.00 M(+3.1%) |
| Dec 2022 | $5.82 M | $5.82 M(+12.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $5.17 M(+8.0%) |
| Jun 2022 | - | $4.79 M(+28.5%) |
| Mar 2022 | - | $3.73 M(+24.4%) |
| Dec 2021 | $3.00 M(-4.7%) | $3.00 M(+81.7%) |
| Sep 2021 | - | $1.65 M(-27.3%) |
| Jun 2021 | - | $2.27 M(-27.8%) |
| Dec 2020 | $3.14 M(+27.9%) | $3.14 M |
| Dec 2019 | $2.46 M | - |
FAQ
- What is MiNK Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for MiNK Therapeutics?
- What is MiNK Therapeutics annual accounts payable year-on-year change?
- What is MiNK Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for MiNK Therapeutics?
- What is MiNK Therapeutics quarterly accounts payable year-on-year change?
What is MiNK Therapeutics annual accounts payable?
The current annual accounts payable of INKT is $3.91 M
What is the all time high annual accounts payable for MiNK Therapeutics?
MiNK Therapeutics all-time high annual accounts payable is $5.82 M
What is MiNK Therapeutics annual accounts payable year-on-year change?
Over the past year, INKT annual accounts payable has changed by -$1.91 M (-32.82%)
What is MiNK Therapeutics quarterly accounts payable?
The current quarterly accounts payable of INKT is $2.36 M
What is the all time high quarterly accounts payable for MiNK Therapeutics?
MiNK Therapeutics all-time high quarterly accounts payable is $6.00 M
What is MiNK Therapeutics quarterly accounts payable year-on-year change?
Over the past year, INKT quarterly accounts payable has changed by $0.00 (0.00%)